RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Cipla USA, Inc. 2025-12-17 Health serious FDA
Health · FDA · Recall #FDA-D-0217-2026

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx… Recall

Issued December 17, 2025 · Cipla USA, Inc.

In December 2025, Cipla USA, Inc. recalled the Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx…, a serious health recall reported by the FDA.

Compiled by Maya Ellison, RecallCheckr

What this means for you

Failed stability specifications: Out of specification for hardness test

What you should do

  1. 1 Stop using Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Cipla USA, Inc. to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Cipla USA, Inc.
Category
Health
Recall date
December 17, 2025
Units affected
Not reported
Sold at
Nationwide in the USA
Recall number
FDA-D-0217-2026
Made in
United States
Issuing agency
FDA

In context

  • Cipla USA, Inc. has 9 recalls in our database.
  • We're tracking 3,576 Health recalls in our database.
  • This is the 691st Health recall we've logged in 2025.
Read the official FDA notice

Related recalls